Hyderabad, Telangana May 7, 2018 (Issuewire.com) - Pharmascroll, a Pharmaceutical market research and business consulting firm, would be offering Monthly Market Intelligence reports on multiple disease indications both on a standalone and subscription basis. Pharmascroll launched its operations in June 2017, and since then has been offering quality Market Research services in various disease indications. The company on the back of its successful engagement with Market Research clients and superior research and competitive tracking capabilities across indications has now decided to offer Market intelligence reports monthly.
“Pharmascroll understands that because of the increasing research and commercialization spends, on Pharmaceutical drugs, incurred by the firms, it becomes imperative for the firms to keep a close watch on the competitor activities in the market and prepare well in advance to gain or retain the majority share in the market. Pharmascroll, attributed to its extensive research capabilities, can help the firms track the competition by providing timely alerts of the competitor activities and their potential implications as well as help the firms apprise themselves of the evolving market trends and innovations in the disease area of interest.”, says Bhawna Gupta, Director, Pharmascroll.
Major Sections of the reports:
Disease Indication Overview
This section gives the overview of the disease indication in detail. The section highlights the basic definition, causes and symptoms of a disease, profile of patients and multiple methods through which the patient can be diagnosed with the disease.
Market Intelligence Information Overview and Potential Implications
The reports cover in detail the following market updates in the form of major research events in the disease area of interest
- Detailed Congress coverage and events updates
- Clinical Trial results and updates
- Latest Research findings from scientific institutions and observational/interventional studies
- Regulatory bodies updates
- Patients and Physicians findings from multiple sources
- Latest updates related to drugs and other activities from Companies, operating and researching in the disease indication which further include
- Drug approval events
- Clinical updates for drugs including new Safety and Regulatory warnings from Regulatory bodies
- Promotional activities
- Investor events
- Mergers and Acquisitions details
The reports further detail the potential implications of every event covered, on the Market and the Pharmaceutical firms researching or marketing their drugs in the disease area, both in short-term and long-term. This, in turn, would enable firms to keep a close watch on the competitor drugs in the market and prepare well in advance for the implications of competitor activities to gain or retain the majority share in the market.
Disease Indications covered:
Pharmascroll further announced that the reports would be available across multiple indications in the disease areas as mentioned.
- Neurology and Psychiatry Indications (Migraine, MS, Bipolar disorders, Alzheimer’s disease, Epilepsy, Parkinson’s Disease)
- Cardiovascular Indications (ACS, HF, Hypertension)
- Respiratory Indications (Asthma, COPD, CF, IPF, Allergic Rhinitis)
- Oncology Indications
- Gastro-Intestinal Indications
- Immunology Indications (Rheumatoid Arthritis, Psoriasis, Lupus)
- Dermatology disorders (Acne, Atopic Dermatitis, Urticaria)
- Metabolic disorders (Diabetes, Obesity, Dyslipidemia)
- Musculoskeletal Indications (Osteoporosis)
- Blood-related disorders
- Infectious Diseases (HIV, Hepatitis C, Influenza)
- Hormonal disorders
- Reproduction-related disorders
- Surgical procedures
- Renal disorders
- Rare Diseases
- Vaccines
Pharmascroll can be reached out at enquiry@pharmascroll.com or at +919776868067 for any queries or discussions. To know more details about the company visit www.pharmascroll.com
Media Contact
Pharmascroll Research and Consulting Pvt Ltd bhawna.gupta@pharmascroll.com +919776868067 Hi Tech City, Hyderabad, India, Zip-500084 https://pharmascroll.com/
